BiotechTube
Home/BioInvent International/Cecilia Hofvander
CH

Cecilia Hofvander

SVP, Clinical Development

BioInvent International

Therapeutic Areas

OncologyImmuno-oncology

BioInvent International Pipeline

DrugIndicationPhase
BI-1206Non-Hodgkin's LymphomaPhase 1/2
BI-1808Advanced Solid TumorsPhase 1/2
BI-1607Advanced Solid TumorsPhase 1/2
BT-001Solid TumorsPhase 1/2

Leadership Team at BioInvent International

MW
Martin Welschof
Chief Executive Officer
BF
Björn Frendéus
Founder & Chief Scientific Officer
MO
Michael Oredsson
President & Head of Business Development
AS
Anders Svensson
Chief Financial Officer
View full BioInvent International profile